- Home
- SUPN vs AVAH Comparison
SUPN vs AVAH Comparison
Compare SUPN & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- AVAH
- Stock Information
- Founded
- SUPN 2005
- AVAH 1984
- Country
- SUPN United States
- AVAH United States
- Employees
- SUPN N/A
- AVAH N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- AVAH Hospital/Nursing Management
- Sector
- SUPN Health Care
- AVAH Health Care
- Exchange
- SUPN Nasdaq
- AVAH Nasdaq
- Market Cap
- SUPN 2.6B
- AVAH 2.1B
- IPO Year
- SUPN 2012
- AVAH 2021
- Fundamental
- Price
- SUPN $54.61
- AVAH $9.46
- Analyst Decision
- SUPN Strong Buy
- AVAH Buy
- Analyst Count
- SUPN 3
- AVAH 7
- Target Price
- SUPN $62.67
- AVAH $8.36
- AVG Volume (30 Days)
- SUPN 725.2K
- AVAH 1.7M
- Earning Date
- SUPN 11-04-2025
- AVAH 11-06-2025
- Dividend Yield
- SUPN N/A
- AVAH N/A
- EPS Growth
- SUPN 1411.53
- AVAH N/A
- EPS
- SUPN 1.14
- AVAH 0.09
- Revenue
- SUPN $665,125,000.00
- AVAH $2,177,672,000.00
- Revenue This Year
- SUPN $7.31
- AVAH $16.37
- Revenue Next Year
- SUPN $21.87
- AVAH $6.66
- P/E Ratio
- SUPN $46.18
- AVAH $99.40
- Revenue Growth
- SUPN 5.55
- AVAH 11.54
- 52 Week Low
- SUPN $29.16
- AVAH $3.67
- 52 Week High
- SUPN $53.28
- AVAH $10.32
- Technical
- Relative Strength Index (RSI)
- SUPN 78.22
- AVAH 56.89
- Support Level
- SUPN $49.95
- AVAH $8.73
- Resistance Level
- SUPN $52.15
- AVAH $10.32
- Average True Range (ATR)
- SUPN 1.36
- AVAH 0.39
- MACD
- SUPN 0.30
- AVAH -0.05
- Stochastic Oscillator
- SUPN 97.61
- AVAH 52.24
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.